Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 826–827 | Cite as

ASO Author Reflections: Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors

  • Alexandra G. Lopez-Aguiar
  • Kenneth Cardona
ASO Author Reflections



Alexandra G. Lopez-Aguiar and Kenneth Cardona have no conflicts of interest to disclose.


  1. 1.
    Dickson PV, Behrman SW. Management of pancreatic neuroen- docrine tumors. Surg Clin North Am. 2013;93:675–91.CrossRefGoogle Scholar
  2. 2.
    Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E. Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors. Scand J Gastroenterol. 2014;49:734–41.CrossRefGoogle Scholar
  3. 3.
    Lowe K, Khithani A, Liu E, et al. Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size? J Surg Oncol. 2012;106:724–27.CrossRefGoogle Scholar
  4. 4.
    Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321–25.CrossRefGoogle Scholar
  5. 5.
    Lopez-Aguiar AG, Ethun CG, Postlewait LM, et al. Redefining the Ki-67 index stratification for low-grade pancreatic neuroendocrine tumors: improving its prognostic value for recurrence of disease. Ann Surg Oncol. 2018;25:290–98.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Surgical OncologyWinship Cancer Institute, Emory UniversityAtlantaUSA

Personalised recommendations